SCHEMBL7339273

SCHEMBL7339273

N=C(N)Nc1cccc(C(=O)NCC(=O)NC(CC(=O)O)C(F)(F)F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
ITGB3 P05106 10/20 0.45
ITGB1 P05556 8/20 0.45
ITGAV P06756 8/20 0.45
ITGA5 P08648 8/20 0.45
ITGB5 P18084 2/20 0.45
ITGB6 P18564 2/20 0.45
ITGB8 P26012 2/20 0.45
ITGA8 P53708 2/20 0.45
MDM2 Q00987 5/20 0.44
GPR139 Q6DWJ6 5/20 0.44
MDM4 O15151 3/20 0.44
ITGA2B P08514 2/20 0.43
EPHX2 P34913 1/20 0.40
PARP1 P09874 1/20 0.40
PARP10 Q53GL7 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ATM Q13315 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7343772 0.87 HTT (0.41) HTTL3MBTL1ITGB3GPR139ITGA2B
SCHEMBL6780097 0.86 ITGB3 (0.47) HTTL3MBTL1ITGB3ITGB1ITGAV
SCHEMBL7339304 0.86 ITGB3 (0.45) HTTL3MBTL1ITGB3ITGB1ITGAV
SCHEMBL30083944 0.85 ITGB3 (0.51) HTTL3MBTL1ITGB3ITGB1ITGAV
SCHEMBL7840865 0.84 ITGB3 (0.46) HTTL3MBTL1ITGB3ITGB1ITGAV
SCHEMBL18269210 0.84 ITGB3 (0.48) HTTL3MBTL1ITGB3ITGB1ITGAV
Trifluoroacetic Acid SCHEMBL3835291 0.84 ITGB3 (0.51) HTTL3MBTL1ITGB3ITGB1ITGAV
SCHEMBL18271386 0.83 ITGB3 (0.49) HTTL3MBTL1ITGB3ITGB1ITGAV
SCHEMBL6776384 0.83 ITGB3 (0.45) HTTL3MBTL1ITGB3ITGB1ITGAV
SCHEMBL6777933 0.83 ITGB3 (0.64) HTTL3MBTL1ITGB3ITGB1ITGAV

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0850221-B1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS SEARLE & CO (US) 2001-07-18 EP claimed
EP-0850221-A1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS G.D. SEARLE & CO. (US) 1998-07-01 EP claimed
WO-1997008145-A1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS G.D. SEARLE & CO. (US) 1997-03-06 WO claimed
EP-0850221-B1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS SEARLE & CO (US) 2001-07-18 EP disclosed
US-6028223-A AN INTEGRIN ANTAGONISTS TREATING BONE DISORDER, PERIODONTAL DISEASE, OSTEOPOROSIS, HUMORAL HYPERCALCEMIA OF MALIGNANCY, PAGET'S DISEASE, TUMOR ANGIOGENESIS, DIABETIC RETINOPATHY, ARTHRITIS, SMOOTH MUSCLE CELL MIGRATION AND RESTENOSIS G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0850221-A1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS G.D. SEARLE & CO. (US) 1998-07-01 EP disclosed
WO-1997008145-A1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS G.D. SEARLE & CO. (US) 1997-03-06 WO disclosed